DV
Dividend Vision

CSDX — CS Diagnostics Corp.

CS Diagnostics Corp. (CSDX)

Its deepest 1-year drawdown was 91.8%.

CS Diagnostics Corp. designs, manufactures, and sells wellness and medical products globally, including MEDUSA, a proprietary surface disinfectant protection product, and CS-Protect Hydrogel, a proprietary oncology medical device used in radiation therapy. The company does not currently have a known distribution rate. This equity security may appeal to investors seeking exposure to the medical devices and diagnostics sector.

CSDX key facts

Asset type
Stock
Asset class
Equity
Inception date
02/17/2005
Distribution frequency
None
Last close
$0.07
Market cap
$17,499,454
Average volume
0.0
Payout ratio
0.0
P/E ratio
0.0
Forward P/E
0.0
EPS
$0.00